Abstract
The many improvements in diagnostic and therapeutic tools over the last half-century have changed the prospects for patients with renal cell carcinoma (RCC). Higher survival rates and less morbidity have been achieved. The disease is, however, still unpredictable and represents many unsolved problems.
In this paper we focus on determinants of the natural and clinical course of RCC and the changes in regard to this over the last decades.
References
1.
Flocks
RH
Kadesky
MC
Malignant neoplasms of the kidney; an analysis of 353 patients followed five years or more . J Urol
1958 ;79 :196 –201 .
2.
Robson
CJ
Churchill
BM
Anderson
W
The results of radical nephrectomy for renal cell carcinoma . J Urol
1969 ;101 :297 –301 .
3.TNM classification of malignant tumours, International Union Against Cancer CH . Wiley-Liss, Inc.
1997 pp. 180 –182 .
4.
Tsui
K-H
Shvarts
O
Smith
RB
Figlin
R
DeKernion
JB
Belldegrun
A
Renal cell carcinoma: Prognostic significance of incidentally detected tumors . J Urol
2000 ;163 :426 –430 .
5.
Javidan
J
Stricker
HJ
Tamboli
P
Amin
MB
Peabody
JO
Deshpande
A
Menon
M
Amin
MB
Prognostic significance of the 1997 TNM classification of renal cell carcinoma . J Urol
1999 ;162 :1277 –1281 .
6.
Gofrit
ON
Shapiro
A
Kovalski
N
Landau
EH
Shenfeld
OZ
Pode
D
Renal cell carcinoma: Evaluation of the 1997 TNM system and recommendations for follow-up after surgery . Eur Urol
2001 ;39 :669 –674 .
7.
Ljungberg
B
Alamdari
FI
Rasmuson
T
Roos
G
Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy . BJU Int
1999 ;84 :405 –411 .
8.
Beisland
C
Medby
PC
Beisland
HO
Kidney cancer — A retrospective study of 368 patients . Tidsskr Nor Laegefor
2002 ;122 :2341 –2345 .
9.
Gudbjartsson
T
Einarsson
GV
Magnusson
J
A population-based analysis of survival and incidental diagnosing of renal cell carcinoma patients in Iceland 1971–1990 . Scand J Urol Nephrol
1996 ;30 :451 –455 .
10.
Polascik
TJ
Proud
CR
Meng
MV
Partin
AW
Marshall
FF
Partial nephrectomy: Technique, complications and pathological findings . J Urol
1995 ;154 :1312 –18 .
11.
Oda
T
Miyao
N
Takahashi
A
Yanase
M
Masumori
N
Itoh
N
Tamakawa
M
Tsukamoto
T
Growth rates of primary and metastatic lesions of renal cell carcinoma . Int J Urol
2001 ;8 :473 –477 .
12.
Hellsten
S
Berge
T
Wehlin
L
Unrecognized renal cell carcinoma. Clinical and pathological aspects . Scand J Urol Nephrol
1981 ; 15 : 273 –278 .
13.
Duchene
DA
Lotan
Y
Cadeddu
JA
Sagalowsky
AI
Koeneman
KS
Histopathology of surgically managed renal tumors: Analysis of a contemporary series . Urology
2003 ;62 :827 –830 .
14.
Fuhrman
SA
Lasky
LC
Limas
C
Prognostic significance of morphologic parameters in renal cell carcinoma . Am J Surg Pathol
1982 ;6 :655 –663 .
15.
Ljungberg
B
Landberg
G
Alamdari
FI
Factors of importance for prediction of survival in patients with metastatic renal cell carcinoma, treated with or without nephrectomy . Scand J Urol Nephrol
2000 ;34 :246 –251 .
16.
Zisman
A
Pantuck
Dorey F
Improved prognostication of renal cell carcinoma using an intergrated staging system . J Clin Oncol
2001 ;19 :1649 –57 .
17.
Beisland
C
Medby
PC
Beisland
HO
Presumed radically treated renal cell carcinoma: Recurrence of the disease and prognostic factors for survival thereafter . Scand J Urol Nephrol . In Press 2004 .
18.
Jacobsen
J
Grankvist
K
Rasmuson
T
Bergh
A
Landberg
G
Ljungberg
B
Expression of vascular endothelial growth factor protein in human renal cell carcinoma . BJU Int
2004 ;93 :297 –302 .
19.
Bui
MHT
Seligson
D
Han
K
Pantuck
AJ
Dorey
FJ
Huang
Y
Horvath
S
Leibovich
BC
Chopra
S
Liao
SY
Stanridge
E
Lerman
MI
Palotie
A
Fiblin
RA
Belldegrun
AS
Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: Implications for prognosis and therapy . Clin Cancer Res
2003 ;9 :802 –811 .
20.
Beisland
C
Medby
PC
Beisland
HO
Renal cell carcinoma: Gender difference in incidental detection and cancer-specific survival . Scand J Urol Nephrol
2002 ;36 :414 –418 .
21.
http://www.ssb.no/english/subjects/03/01/10
Statistics Norway, causes of death ).
22.
Leibovitch
I
Raviv
G
Mor
Y
Nativ
O
Goldwasser
B
Reconsidering the necessity of ipsilateral adrenalectomy during radical nephrectomy for renal cell carcinoma . Urology
1995 ;46 :316 –320 .
23.
Steinbach
F
Stockle
M
Muller
SC
Thuroff
JW
Melchior
SW
Stein
R
Hohenfeller
R
Conservative surgery of renal cell tumors in 140 patients: 21 years of experience . J Urol
1992 ;148 :24 –29 .
24.
Flanigan
RC
Salmon
SE
Blumenstein
BA
Bearman
SI
Roy
V
McGrath
PC
Caton
IR
Jr
Munshi
N
Crawford
ED
Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer . N Engl J Med
2001 ; 345 : 1655 –1659 .
25.
Mickisch
GH
Garin
A
van Poppel
H
de Prijck
L
Sylvester
R
; European Organisation for Research and Treatment of Cancer (EORTC) Genitourinary Group: Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: A randomised trial . Lancet
2001 ;358 :966 –970 .
26.
Bennett
RT
Lerner
SE
Taub
HC
Dutcher
JP
Fleischmann
J
Cytoreductive surgery for stage IV renal cell carcinoma . J Urol
1995 ;154 :32 –34 .
27.
Beisland
C
Medby
PC
Sander
S
Beisland
HO
Nephrectomy — Indications, complications and postoperative mortality in 646 consecutive cases . Eur Urol
2000 ;37 :58 –64 .
28.
Marcus
SG
Choyke
PL
Reiter
R
Jaffe
GS
Alexander
RB
Linehan
WM
Rosenberg
SA
Walther
MM
Regression of metastatic renal cell carcinoma after cytoreductive nephrectomy . J Urol
1993 ;150 :463 –466 .
29.
Levy
DA
Slaton
JW
Dinney
CPN
Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma . J Urol
1998 ;159 :1163 –1167 .
30.
Sandock
DS
Seftel
AD
Resnick
MI
A new protocol for the followup of renal cell carcinoma based on pathological stage . J Urol
1995 ;154 :28 –31 .
31.
McNichols
DW
Segura
JW
De Weerd
Renal cell carcinoma: Long-term survival and late recurrence . J Urol
1981 ;126 :17 –22 .